AstraZeneca strikes $1.5b AI drug discovery deal with Insitro

AstraZeneca and Insitro have signed a deal worth up to $1.5 billion for AI-driven drug discovery. AstraZeneca will pay $40 million upfront.

• Deal value is up to $1.5 billion
• AstraZeneca pays $40 million upfront
• Partnership covers AI drug discovery